This brand name is authorized in Poland
The drug MYBRACIN contains a combination of these active pharmaceutical ingredients (APIs):
1
Tobramycin
UNII VZ8RRZ51VK - TOBRAMYCIN
|
Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations. |
2
Dexamethasone
UNII 7S5I7G3JQL - DEXAMETHASONE
|
Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
S02CA06 | Dexamethasone and antiinfectives | S Sensory organs → S02 Otologicals → S02C Corticosteroids and antiinfectives in combination → S02CA Corticosteroids and antiinfectives in combination |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: PL | Rejestru Produktรณw Leczniczych | Identifier(s): 100300880 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.